Your browser does not support JavaScript or it may be disabled!
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
Get Realtime News
on your webpage

About 884 results for "bristol"

Bristol-Myers Squibb (BMY) Stock Price Target Increased at BMO

24.4% Return Seen to Date on SmarTrend Bristol-Myers Squibb Ca...

SmarTrend identified an Uptrend for Bristol-Myers Squibb (NYSE:BMY) on October 22nd, 2014 at $51.99. In approximately 5 months, Bristol-Myers Squibb has returned 24.45% as of today's recent price, 6 days ago
Sky Sports

Everton Ladies leave it late

Gabby George scored in extra-time to secure Everton a 2-1 victory over Bristol Academy and a place in the quarter-finals of the FA Women's Cup. Nikki Watts gave Bristol the lead from the penalty spot just before the hour-mark before Lucy Whipp ...
 Sky Sports1 week ago Everton 2-1 Bristol Academy (aet)  BBC1 week ago Bristol Academy WFC loses out on Wembley  ITV.com1 week ago Everton v Bristol Academy (Tues)  BBC1 week ago

Bristol City 'my best move' - Little

Defender Mark Little says joining Football League Trophy winners Bristol City was the best decision he has
 BBC1 week ago Bristol City claim JPT success  Sky Sports1 week ago Bristol City make it 2-0 against Walsall in JPT Final  ITV.com1 week ago Half time: Bristol City 1 - 0 Walsall  ITV.com1 week ago
Pharma Letter

Europe pushes back verdict on Bristol immune system cancer drug

LONDON (Reuters) - European regulators have postponed a decision on whether to recommend approval of a closely watched Bristol-Myers Squibb drug that helps the immune system fight cancer, officials said on Friday. Nivolumab, which is already approved in the ...
 Reuters5 days ago Bristol-Myers buys global license to discovery research programme focused on autoimmune diseases from Novo Nordisk  PharmaBiz1 week ago Novo Nordisk Sheds Autoimmune Portfolio to BMS  PharmaAsia6 days ago Bristol-Myers acquires rights to Novo Nordisk program focused on autoimmune diseases24-03-2015  Pharma Letter1 week ago

'Poo bus' starts regular service

The UK's first bus powered entirely by human and food waste has gone into into full service in Bristol after testing. The 40-seat "Bio-Bus", which runs on biomethane gas generated from sewage and food waste, was trialled at weekends earlier in the ...
 BBC6 days ago Bio-bus powered by human waste goes into service  ITV.com1 week ago New bus services provided at Somerdale  Noodls6 days ago Bio-Bus enters regular service for Bristol trial  Bus and Coach Professional Magazine1 week ago

Bats obey 'traffic rules' when foraging for food

. Researchers from the University of Bristol studied pairs of Daubenton's bats (Myotis daubentonii) foraging low over water for stranded insects at a site near the village of Barrow Gurney in Somerset. "Collective movements of flocking birds or shoaling fish ...
 Business Standard5 days ago Bats avoid collisions by following set of 'traffic rules' while trawling for food  Business Standard5 days ago Bats obey their own 'traffic rules' when looking for food  Prokerala5 days ago

Pembrolizumab Bests Ipilimumab in Melanoma Trial

Pembrolizumab ( Keytruda , Merck) has bested ipilimumab ( Yervoy , Bristol-Myers Squibb) in the treatment of advanced melanoma in a head-to-head clinical trial, according to an announcement today from Merck. Pembrolizumab demonstrated a ...
 Dermatology Online Journal1 week ago Merck's Keytruda tops Bristol-Myers' Yervoy in melanoma trial  Seeking Alpha1 week ago Keytruda beats Yervoy and edges ahead of Opdivo in first-line melanoma  Scrip1 week ago Merck & Co.'s Keytruda bests Bristol-Myers Squibb's Yervoy in advanced melanoma study  FirstWord Pharma1 week ago

Bristol-Myers Squibb Falls 2.80% on Heavy Volume: Watch For Potential Rebound

Bristol-Myers Squibb (NYSE:BMY) traded in a range yesterday that spanned from a low of $65.54 to a high of $67.26. Yesterday, the shares fell 2.8%, which took the trading range below the 3-day low of $67.29 on volume of 10.5 million shares. Often ...
 Individual.com1 week ago SmarTrend Watching for Potential Rebound in Shares of Bristol-Myers Squibb After 2.80% Loss  Individual.com1 week ago

Bristol Myers (BMY) Trading Near $67.88 Resistance Level

After TuesdayaEUR(TM)s trading in Bristol-Myers Squibb Co ("BMY)'s patented algorithms uncovered a trade that offers a 2.56% return or 18.29% on an annualized basis (for ...
 Individual.com6 days ago Bristol Myers (BMY) Showing Support Near $66.07  Individual.com1 week ago

Oskar Pycroft thanks fundraisers after target for life-changing operation reached

Six-year-old Bristol City fan Oskar Pycroft will be at Ashton Gate today. He has cerebral palsy, and will be thanking those who helped raise the money needed for a life-changing operation. The £50,000 target was reached at the weekend after f, ...
 ITV.com1 week ago Walkers raising money for Bristol City fan Oskar Pycroft  ITV.com1 week ago Oskar's mum thanks his supporters  ITV.com1 week ago Oskar celebrates reaching his target at Ashton Gate  ITV.com1 week ago
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts


Realtime News

on your Webpage

Add Widget >Get your members hooked!
Related Queries - bristol
Get updated on latest news & your favorite topics right in your inbox!
More     Less